Coverage
-
July 23, 2019
A D.C. federal judge on Monday tossed a U.S. Food and Drug Administration decision that blocked a Braeburn Inc. drug that fights opioid-addiction from reaching the market, saying the agency needs to take another look at whether a rival drug's exclusivity barred final approval of Braeburn's.
2 other articles on this case.
View all »